IFNB1 and central nervous system cancer: Although viral vector-based gene delivery is not cancer tissue-specific, several studies have demonstrated that IFNβ gene therapy using adenoviral vectors is effective in several cancers such as ovarian cancer [11], bladder cancer [12], glioma [13], and lung cancer [14].